Cargando…

Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus

Swine testis (ST) cell cultures were treated with various doses of recombinant human interferon-alpha 2a (IFN), and assayed for 2′,5′ oligoadenylate synthetase (2–5 A synthetase) activity. Treatment with 100 or 1000 units/ml of IFN resulted in increased 2–5 A synthetase activity, but there was no si...

Descripción completa

Detalles Bibliográficos
Autores principales: Jordan, L.T., Derbyshire, J.B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 1995
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117519/
https://www.ncbi.nlm.nih.gov/pubmed/7653029
http://dx.doi.org/10.1016/0378-1135(94)00118-G
_version_ 1783514389840658432
author Jordan, L.T.
Derbyshire, J.B.
author_facet Jordan, L.T.
Derbyshire, J.B.
author_sort Jordan, L.T.
collection PubMed
description Swine testis (ST) cell cultures were treated with various doses of recombinant human interferon-alpha 2a (IFN), and assayed for 2′,5′ oligoadenylate synthetase (2–5 A synthetase) activity. Treatment with 100 or 1000 units/ml of IFN resulted in increased 2–5 A synthetase activity, but there was no significant response to 1 unit/ml of IFN. Titres of porcine transmissible gastroenteritis virus (TGEV) were reduced between 6 and 15 hours post-infection in ST cells treated with 1000 or 2500 units/ml of IFN. Polyacrylamide gel electrophoresis of lysates of TGEV-infected ST cells, and of lysates immunoprecipitated with anti-TGEV antibodies, revealed that the synthesis of the N and S proteins of TGEV was reduced in cells treated with 100 or 1000 units/ml of IFN. Viral RNA production, as determined with a probe which hybridized to the S gene of TGEV, was found to be reduced in ST cells treated with 1000 units/ml of IFN, but not in cells treated with 100 units/ml. It was concluded that, in IFN-treated ST cells, TGEV protein production may be decreased in the absence of reduced viral RNA production, and that 2–5 A synthetase may not be a significant factor in the antiviral activity of IFN against TGEV.
format Online
Article
Text
id pubmed-7117519
institution National Center for Biotechnology Information
language English
publishDate 1995
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71175192020-04-02 Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus Jordan, L.T. Derbyshire, J.B. Vet Microbiol Article Swine testis (ST) cell cultures were treated with various doses of recombinant human interferon-alpha 2a (IFN), and assayed for 2′,5′ oligoadenylate synthetase (2–5 A synthetase) activity. Treatment with 100 or 1000 units/ml of IFN resulted in increased 2–5 A synthetase activity, but there was no significant response to 1 unit/ml of IFN. Titres of porcine transmissible gastroenteritis virus (TGEV) were reduced between 6 and 15 hours post-infection in ST cells treated with 1000 or 2500 units/ml of IFN. Polyacrylamide gel electrophoresis of lysates of TGEV-infected ST cells, and of lysates immunoprecipitated with anti-TGEV antibodies, revealed that the synthesis of the N and S proteins of TGEV was reduced in cells treated with 100 or 1000 units/ml of IFN. Viral RNA production, as determined with a probe which hybridized to the S gene of TGEV, was found to be reduced in ST cells treated with 1000 units/ml of IFN, but not in cells treated with 100 units/ml. It was concluded that, in IFN-treated ST cells, TGEV protein production may be decreased in the absence of reduced viral RNA production, and that 2–5 A synthetase may not be a significant factor in the antiviral activity of IFN against TGEV. Published by Elsevier B.V. 1995-06 2000-03-10 /pmc/articles/PMC7117519/ /pubmed/7653029 http://dx.doi.org/10.1016/0378-1135(94)00118-G Text en Copyright © 1995 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Jordan, L.T.
Derbyshire, J.B.
Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus
title Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus
title_full Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus
title_fullStr Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus
title_full_unstemmed Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus
title_short Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus
title_sort antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117519/
https://www.ncbi.nlm.nih.gov/pubmed/7653029
http://dx.doi.org/10.1016/0378-1135(94)00118-G
work_keys_str_mv AT jordanlt antiviralactionofinterferonalphaagainstporcinetransmissiblegastroenteritisvirus
AT derbyshirejb antiviralactionofinterferonalphaagainstporcinetransmissiblegastroenteritisvirus